Private-equity firm KKR & Co. is nearing a deal to sell Capsugel to Switzerland’s Lonza Group AG for more than $5 billion, as an auction of the New Jersey drug-capsule maker draws to a close.
from WSJ.com: US Business http://ift.tt/2he9mIS
via IFTTT
No comments:
Post a Comment